Breaking News: D-Boral Capital Facilitates HWH International’s Successful $1.76 Million Public Offering on Nasdaq

Breaking News: D-Boral Capital Facilitates HWH International’s Successful $1.76 Million Public Offering on Nasdaq Description: BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) — HWH International Inc. (the “Company”) (NASDAQ: HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the “Offering”) with aggregate gross proceeds to the

Read More »

Attention RVNC Investors: Take Action Now! Bronstein, Gewirtz & Grossman LLC Offers Opportunity for Revance Therapeutics Inc. Shareholders to Lead Class Action Lawsuit for Significant Losses

Attention RVNC Investors: Take Action Now! Bronstein, Gewirtz & Grossman LLC Offers Opportunity for Revance Therapeutics Inc. Shareholders to Lead Class Action Lawsuit for Significant Losses By: John Doe Investors in Revance Therapeutics Inc. (NASDAQ: RVNC) have recently been alerted to a class action lawsuit filed against the company and

Read More »

Revolutionizing Treatment: Immix Biopharma Speeds Up Enrollment for Groundbreaking AL Amyloidosis Trial with NXC-201 CAR-T

Revolutionizing Treatment: Immix Biopharma Speeds Up Enrollment for Groundbreaking AL Amyloidosis Trial with NXC-201 CAR-T Immix Biopharma Successfully Completes Phase 1b Segment LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL

Read More »
Receive the latest market news

Subscribe To Our Newsletter

Get notified about market movers